Huang et al. (2013) investigated the use of tumor activatable CPP (termed dtACPP) to label nanoparticles and deliver siRNA targeting vascular endothelial growth factors. The experiments showed effective shutdown of blood vessels and cell apoptosis within the tumor (Huang et al., 2013). The gene discussed is VEGFA; the disease is neoplasm.